NASDAQ · STOCK
Insulet Corporation
$165.32
52W $138.79 – $354.88
55/100
$11.45B
38.4
1.11
Is PODD Bullish or Bearish?
Mixed.
Innellis AI committee rates Insulet Corporation (PODD) Watch with a composite score of 55/100
, based on 6 analysts with 83% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +5.04 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -14.96 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
Some positive signals exist — news sentiment is positive (+0.25 across 4 articles, 14d) — but they are not yet strong enough to justify a Buy. The committee is monitoring for confirmation.
Bull & Bear Case
Bull Case
- ROE of 17.4% shows genuine earnings power backing the valuation — Value
- Revenue growing 31.9% YoY -- genuine top-line momentum — Growth
- 4 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- News sentiment is positive (+0.25 across 4 articles, 14d) — News
Bear Case
- P/E of 38.4 is moderate-to-rich — Value
- Price-to-book of 13.2x prices in significant intangible value — Value
- EPS declining -21.1% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
55/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 55%
of 93 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 17.4% shows genuine earnings power backing the valuation
− P/E of 38.4 is moderate-to-rich
Growth Analyst
neutral
55
/ 100 · High confidence
Moderate growth -- present but not remarkable
+ Revenue growing 31.9% YoY -- genuine top-line momentum
− EPS declining -21.1% YoY despite any revenue growth
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.25 across 4 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 56.7 to 55.0.
- Conviction changed from moderate to high.
- Committee agreement increased notably from 67% to 83%.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
54.1
Neutral
MACD Histogram
0.276
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Lh Ll
Support
$138.81
Resistance
$353.41
Bollinger %B
0.68
Inside Bands
Price vs Moving Averages
EMA 9
$165.02
Above
EMA 21
$162.31
Above
EMA 50
$163.14
Above
EMA 200
$213.17
Below
Fundamental Analysis
Valuation
36
Growth
69
Profitability
1
Financial Health
94
Cash Flow
37
Valuation
P/E Ratio
38.4×
P/B Ratio
8.88×
PEG Ratio
-1.54
Dividend Yield
0.00%
52W High
$354.88
52W Low
$138.79
Quality & Growth
ROE
16.3%
ROA
7.8%
Gross Margin
71.0%
Operating Margin
17.5%
Revenue Growth YoY
—
Debt / Equity
0.73
AI Fundamental Assessment
P/E ratio of 38.4 (rich relative to a 15-40x range); Price-to-book of 8.9x; PEG ratio of -1.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.2%; Return on assets of 0.1%; Net margin of 0.1%; Gross margin of 0.7%; Current ratio of 2.49 (healthy short-term liquidity); Debt-to-equity of 0.73; Free cash flow margin of 0.7% (thin cash generation); Free cash flow per share is positive (5.89); Most recent quarter beat estimates by 16.2%; 4 consecutive earnings beats; EPS growth decelerating (+25.0% -> -8.4% QoQ); Analyst estimates rising over recent quarters
Get the Full PODD Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →